{"id":51545,"date":"2022-12-05T10:02:43","date_gmt":"2022-12-05T09:02:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/"},"modified":"2022-12-05T10:02:43","modified_gmt":"2022-12-05T09:02:43","slug":"bactobio-raises-6-million-to-discover-novel-antimicrobials","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/","title":{"rendered":"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials"},"content":{"rendered":"
\n

LONDON–(BUSINESS WIRE)–#agritech<\/a>–Bactobio Ltd (\u2018Bactobio\u2019 or \u2018the Company\u2019), a biotechnology company uncovering safer and greener antimicrobial solutions from previously unexplored microbes, announced today that it has closed an oversubscribed \u00a36 million bridge financing round. The financing was led by Bridford Group, with support from angel investors Peder Holk Nielsen (Former CEO and President of Novozymes) and Hugh Grant (Former Chairman and CEO of Monsanto). New investors included the founders of the London-based fintech unicorn Lendable and Entangle Group.\n<\/p>\n

<\/a><\/p>\n

\nBactobio is a world leader in capturing and exploring novel biodiversity.\n<\/p>\n

\nThe Company\u2019s unique combination of synthetic biology, next-generation sequencing and machine learning gives exclusive access to a growing library of thousands of previously unscreened microbes.\n<\/p>\n

\nAn interdisciplinary approach then enables a thorough exploration of the potential chemical space, creating unmatched opportunity for new discovery across markets in healthcare, agriculture and bio-derived chemicals.\n<\/p>\n

\nToday\u2019s announced funds will be used to advance Bactobio\u2019s pioneering discovery pipeline and enable characterisation of the next generation of antimicrobial solutions.\n<\/p>\n

\n\u201cWith our 2021 fundraise we built a complete end-to-end compound discovery pipeline. Today\u2019s raise supports our continued drive towards automation and data-driven science that will help turn our captured biodiversity into commercial products,\u201d said Dr Daniel Hansen, CEO and Founder of Bactobio. \u201cWe are immensely proud to receive such a high level of new and continued support from high calibre investors.\u201d\n<\/p>\n

\nDr Mark Wilkinson, CSO at Bactobio, commented \u201cIt is estimated that fewer than 3% of the potential natural products encoded in nature have been identified to-date. Bactobio\u2019s bioactivity-driven but target-agnostic approach lets nature do the work and lead us towards compounds which have been unimaginable and previously inaccessible to drug discovery efforts. Funds from this round will allow us to dig deeper into this previously untapped bioresource.\u201d\n<\/p>\n

\nAbout Bactobio<\/b>\n<\/p>\n

\nBactobio is a London-based biotechnology company using breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to cultivate the 99% of microbes which have previously been unculturable. Bactobio\u2019s exclusive access to the biggest bioresource in life allows them to discover novel chemical and biological products across the pharmaceutical, agricultural and bioderived-chemical sectors. Their first goal is to help solve the growing antimicrobial resistance crisis. For more information visit www.bacto.bio<\/a>. Connect with us at www.twitter.com\/bactobio<\/a> and www.linkedin.com\/company\/bactobio<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nHelena Francis
\n
Head of Business Development, Bactobio Ltd
\n
Helena.francis@bacto.bio<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON–(BUSINESS WIRE)–#agritech–Bactobio Ltd (\u2018Bactobio\u2019 or \u2018the Company\u2019), a biotechnology company uncovering safer and greener antimicrobial solutions from previously unexplored microbes, announced today that it has closed an oversubscribed \u00a36 million bridge financing round. The financing was led by Bridford Group, with support from angel investors Peder Holk Nielsen (Former CEO and President of Novozymes) and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51545","6":"format-standard","7":"category-industry"},"yoast_head":"\nBactobio Raises \u00a36 Million To Discover Novel Antimicrobials - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LONDON–(BUSINESS WIRE)–#agritech–Bactobio Ltd (\u2018Bactobio\u2019 or \u2018the Company\u2019), a biotechnology company uncovering safer and greener antimicrobial solutions from previously unexplored microbes, announced today that it has closed an oversubscribed \u00a36 million bridge financing round. The financing was led by Bridford Group, with support from angel investors Peder Holk Nielsen (Former CEO and President of Novozymes) and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-05T09:02:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221205005059\/en\/1653600\/21\/BACTOBIO_FullLookup_MidRes.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials\",\"datePublished\":\"2022-12-05T09:02:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/\"},\"wordCount\":403,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221205005059\\\/en\\\/1653600\\\/21\\\/BACTOBIO_FullLookup_MidRes.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/\",\"name\":\"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221205005059\\\/en\\\/1653600\\\/21\\\/BACTOBIO_FullLookup_MidRes.jpg\",\"datePublished\":\"2022-12-05T09:02:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221205005059\\\/en\\\/1653600\\\/21\\\/BACTOBIO_FullLookup_MidRes.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221205005059\\\/en\\\/1653600\\\/21\\\/BACTOBIO_FullLookup_MidRes.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bactobio-raises-6-million-to-discover-novel-antimicrobials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/","og_locale":"en_US","og_type":"article","og_title":"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials - Pharma Trend","og_description":"LONDON–(BUSINESS WIRE)–#agritech–Bactobio Ltd (\u2018Bactobio\u2019 or \u2018the Company\u2019), a biotechnology company uncovering safer and greener antimicrobial solutions from previously unexplored microbes, announced today that it has closed an oversubscribed \u00a36 million bridge financing round. The financing was led by Bridford Group, with support from angel investors Peder Holk Nielsen (Former CEO and President of Novozymes) and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-05T09:02:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221205005059\/en\/1653600\/21\/BACTOBIO_FullLookup_MidRes.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials","datePublished":"2022-12-05T09:02:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/"},"wordCount":403,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221205005059\/en\/1653600\/21\/BACTOBIO_FullLookup_MidRes.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/","url":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/","name":"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221205005059\/en\/1653600\/21\/BACTOBIO_FullLookup_MidRes.jpg","datePublished":"2022-12-05T09:02:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221205005059\/en\/1653600\/21\/BACTOBIO_FullLookup_MidRes.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221205005059\/en\/1653600\/21\/BACTOBIO_FullLookup_MidRes.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bactobio-raises-6-million-to-discover-novel-antimicrobials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bactobio Raises \u00a36 Million To Discover Novel Antimicrobials"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51545"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51545\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}